{"entity":{"type":"insider","cik":"0001543112","url":"/insider/0001543112","json_url":"/insider/0001543112.json","name":"Morningside Venture Investments Ltd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":55,"n_filings":32,"first":"2017-11-13","last":"2026-08-05","span_basis":"filed_date"},"name_variants":[{"name":"Morningside Venture Investments Ltd","source":"filing","n_filings":32,"first_seen":"2017-11-13","last_seen":"2026-08-05"}],"transactions":[{"id":5991520,"accession":"0000905148-26-003483","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000905148-26-003483","line_url":"/filing/0000905148-26-003483#line-7","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Apnimed, Inc.","issuer_ticker":"APMD","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":7152713.0,"shares_owned_after_display":"7,152,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-03","filed_date":"2026-08-05","scope":"insider"},{"id":8062557,"accession":"0000899243-23-010078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-010078","line_url":"/filing/0000899243-23-010078#line-1","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29048.0,"shares_display":"29,048","price_per_share":30.45,"price_display":"30.45","price_state":"stated","total_value":884511.6,"total_display":"884,511.60","total_whole":"884,512","shares_owned_after":6997302.0,"shares_owned_after_display":"6,997,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-29","filed_date":"2023-03-31","scope":"insider"},{"id":8010292,"accession":"0000899243-23-009972","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-23-009972","line_url":"/filing/0000899243-23-009972#line-3","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":30.37,"price_display":"30.37","price_state":"stated","total_value":3037000.0,"total_display":"3,037,000.00","total_whole":"3,037,000","shares_owned_after":7026350.0,"shares_owned_after_display":"7,026,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-28","filed_date":"2023-03-29","scope":"insider"},{"id":8010289,"accession":"0000899243-23-009972","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-009972","line_url":"/filing/0000899243-23-009972","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60964.0,"shares_display":"60,964","price_per_share":30.50260809658159,"price_display":"30.50","price_state":"stated","total_value":1859561.0,"total_display":"1,859,561.00","total_whole":"1,859,561","shares_owned_after":7154350.0,"shares_owned_after_display":"7,154,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-27","filed_date":"2023-03-29","scope":"insider","n_lines":2},{"id":8244423,"accession":"0000899243-23-009506","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-009506","line_url":"/filing/0000899243-23-009506","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63448.0,"shares_display":"63,448","price_per_share":31.907932164922457,"price_display":"31.91","price_state":"stated","total_value":2024494.48,"total_display":"2,024,494.48","total_whole":"2,024,494","shares_owned_after":7216121.0,"shares_owned_after_display":"7,216,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-21","filed_date":"2023-03-23","scope":"insider","n_lines":2},{"id":8213373,"accession":"0000899243-23-008858","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-008858","line_url":"/filing/0000899243-23-008858#line-1","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9122.0,"shares_display":"9,122","price_per_share":32.55,"price_display":"32.55","price_state":"stated","total_value":296921.1,"total_display":"296,921.10","total_whole":"296,921","shares_owned_after":7250762.0,"shares_owned_after_display":"7,250,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-16","filed_date":"2023-03-17","scope":"insider"},{"id":8620089,"accession":"0000899243-23-008733","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-23-008733","line_url":"/filing/0000899243-23-008733","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":33.27331306666667,"price_display":"33.27","price_state":"stated","total_value":4990996.96,"total_display":"4,990,996.96","total_whole":"4,990,997","shares_owned_after":7300950.0,"shares_owned_after_display":"7,300,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-15","filed_date":"2023-03-16","scope":"insider","n_lines":2},{"id":8620085,"accession":"0000899243-23-008733","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-008733","line_url":"/filing/0000899243-23-008733#line-1","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70714.0,"shares_display":"70,714","price_per_share":34.54,"price_display":"34.54","price_state":"stated","total_value":2442461.56,"total_display":"2,442,461.56","total_whole":"2,442,462","shares_owned_after":7409884.0,"shares_owned_after_display":"7,409,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-14","filed_date":"2023-03-16","scope":"insider"},{"id":7886457,"accession":"0000899243-23-007120","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-007120","line_url":"/filing/0000899243-23-007120#line-1","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":33.75,"price_display":"33.75","price_state":"stated","total_value":1687500.0,"total_display":"1,687,500.00","total_whole":"1,687,500","shares_owned_after":7480598.0,"shares_owned_after_display":"7,480,598","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-06","scope":"insider"},{"id":8694326,"accession":"0000899243-23-006123","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-23-006123","line_url":"/filing/0000899243-23-006123","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":35.5653318,"price_display":"35.57","price_state":"stated","total_value":1778266.59,"total_display":"1,778,266.59","total_whole":"1,778,267","shares_owned_after":7581709.0,"shares_owned_after_display":"7,581,709","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-23","filed_date":"2023-02-24","scope":"insider","n_lines":2},{"id":8694322,"accession":"0000899243-23-006123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-006123","line_url":"/filing/0000899243-23-006123","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":35.9967224,"price_display":"36.00","price_state":"stated","total_value":1799836.12,"total_display":"1,799,836.12","total_whole":"1,799,836","shares_owned_after":7640682.0,"shares_owned_after_display":"7,640,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-22","filed_date":"2023-02-24","scope":"insider","n_lines":2},{"id":8421561,"accession":"0000899243-23-006394","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-006394","line_url":"/filing/0000899243-23-006394","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":34.7270336,"price_display":"34.73","price_state":"stated","total_value":1736351.68,"total_display":"1,736,351.68","total_whole":"1,736,352","shares_owned_after":7532710.0,"shares_owned_after_display":"7,532,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-22","filed_date":"2023-02-28","scope":"insider","n_lines":2},{"id":8644295,"accession":"0000899243-23-004187","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-004187","line_url":"/filing/0000899243-23-004187#line-2","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":6.883,"price_display":"6.88","price_state":"stated","total_value":275320.0,"total_display":"275,320.00","total_whole":"275,320","shares_owned_after":5447993.0,"shares_owned_after_display":"5,447,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-07","scope":"insider"},{"id":8644291,"accession":"0000899243-23-004187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-004187","line_url":"/filing/0000899243-23-004187#line-1","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":7.146,"price_display":"7.15","price_state":"stated","total_value":178650.0,"total_display":"178,650.00","total_whole":"178,650","shares_owned_after":5487993.0,"shares_owned_after_display":"5,487,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-03","filed_date":"2023-02-07","scope":"insider"},{"id":7834000,"accession":"0000899243-23-003869","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-003869","line_url":"/filing/0000899243-23-003869#line-2","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":7.19,"price_display":"7.19","price_state":"stated","total_value":359500.0,"total_display":"359,500.00","total_whole":"359,500","shares_owned_after":5512993.0,"shares_owned_after_display":"5,512,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-02","filed_date":"2023-02-03","scope":"insider"},{"id":7833996,"accession":"0000899243-23-003869","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-003869","line_url":"/filing/0000899243-23-003869#line-1","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":6.95,"price_display":"6.95","price_state":"stated","total_value":278000.0,"total_display":"278,000.00","total_whole":"278,000","shares_owned_after":5562993.0,"shares_owned_after_display":"5,562,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-03","scope":"insider"},{"id":8669081,"accession":"0000899243-23-003120","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-003120","line_url":"/filing/0000899243-23-003120#line-2","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":7.08,"price_display":"7.08","price_state":"stated","total_value":212400.0,"total_display":"212,400.00","total_whole":"212,400","shares_owned_after":5602993.0,"shares_owned_after_display":"5,602,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-01","scope":"insider"},{"id":8669076,"accession":"0000899243-23-003120","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-003120","line_url":"/filing/0000899243-23-003120#line-1","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":6.91,"price_display":"6.91","price_state":"stated","total_value":207300.0,"total_display":"207,300.00","total_whole":"207,300","shares_owned_after":5632993.0,"shares_owned_after_display":"5,632,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-02-01","scope":"insider"},{"id":7799499,"accession":"0000899243-23-002854","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002854","line_url":"/filing/0000899243-23-002854#line-1","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":6.85,"price_display":"6.85","price_state":"stated","total_value":342500.0,"total_display":"342,500.00","total_whole":"342,500","shares_owned_after":5662993.0,"shares_owned_after_display":"5,662,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-25","filed_date":"2023-01-27","scope":"insider"},{"id":8387845,"accession":"0000899243-23-002677","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-002677","line_url":"/filing/0000899243-23-002677#line-2","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":6.98,"price_display":"6.98","price_state":"stated","total_value":558400.0,"total_display":"558,400.00","total_whole":"558,400","shares_owned_after":5712993.0,"shares_owned_after_display":"5,712,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-24","filed_date":"2023-01-25","scope":"insider"},{"id":8387838,"accession":"0000899243-23-002677","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002677","line_url":"/filing/0000899243-23-002677#line-1","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":6.81,"price_display":"6.81","price_state":"stated","total_value":544800.0,"total_display":"544,800.00","total_whole":"544,800","shares_owned_after":5792993.0,"shares_owned_after_display":"5,792,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-25","scope":"insider"},{"id":8279072,"accession":"0000899243-23-002157","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002157","line_url":"/filing/0000899243-23-002157#line-1","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6114.0,"shares_display":"6,114","price_per_share":6.79,"price_display":"6.79","price_state":"stated","total_value":41514.06,"total_display":"41,514.06","total_whole":"41,514","shares_owned_after":5872993.0,"shares_owned_after_display":"5,872,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider"},{"id":8244089,"accession":"0000899243-23-001846","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-001846","line_url":"/filing/0000899243-23-001846#line-2","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1971.0,"shares_display":"1,971","price_per_share":7.15,"price_display":"7.15","price_state":"stated","total_value":14092.65,"total_display":"14,092.65","total_whole":"14,093","shares_owned_after":5879107.0,"shares_owned_after_display":"5,879,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-13","filed_date":"2023-01-17","scope":"insider"},{"id":8244079,"accession":"0000899243-23-001846","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-001846","line_url":"/filing/0000899243-23-001846#line-1","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":6.77,"price_display":"6.77","price_state":"stated","total_value":33850.0,"total_display":"33,850.00","total_whole":"33,850","shares_owned_after":5881078.0,"shares_owned_after_display":"5,881,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-12","filed_date":"2023-01-17","scope":"insider"},{"id":8062066,"accession":"0000899243-23-001293","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-001293","line_url":"/filing/0000899243-23-001293#line-2","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":6.89,"price_display":"6.89","price_state":"stated","total_value":20670.0,"total_display":"20,670.00","total_whole":"20,670","shares_owned_after":5886078.0,"shares_owned_after_display":"5,886,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-06","filed_date":"2023-01-09","scope":"insider"},{"id":8062061,"accession":"0000899243-23-001293","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-001293","line_url":"/filing/0000899243-23-001293#line-1","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12162.0,"shares_display":"12,162","price_per_share":6.97,"price_display":"6.97","price_state":"stated","total_value":84769.14,"total_display":"84,769.14","total_whole":"84,769","shares_owned_after":5889078.0,"shares_owned_after_display":"5,889,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":8694120,"accession":"0000899243-23-000979","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-23-000979","line_url":"/filing/0000899243-23-000979#line-3","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":7.17,"price_display":"7.17","price_state":"stated","total_value":215100.0,"total_display":"215,100.00","total_whole":"215,100","shares_owned_after":5901240.0,"shares_owned_after_display":"5,901,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-05","scope":"insider"},{"id":8694116,"accession":"0000899243-23-000979","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-000979","line_url":"/filing/0000899243-23-000979#line-2","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":7.1,"price_display":"7.10","price_state":"stated","total_value":3550.0,"total_display":"3,550.00","total_whole":"3,550","shares_owned_after":5931240.0,"shares_owned_after_display":"5,931,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":8694113,"accession":"0000899243-23-000979","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-000979","line_url":"/filing/0000899243-23-000979#line-1","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":7.1,"price_display":"7.10","price_state":"stated","total_value":177500.0,"total_display":"177,500.00","total_whole":"177,500","shares_owned_after":5931740.0,"shares_owned_after_display":"5,931,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-29","filed_date":"2023-01-05","scope":"insider"},{"id":6878271,"accession":"0000899243-22-032974","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-032974","line_url":"/filing/0000899243-22-032974#line-2","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3612.0,"shares_display":"3,612","price_per_share":8.8199,"price_display":"8.82","price_state":"stated","total_value":31857.4788,"total_display":"31,857.48","total_whole":"31,857","shares_owned_after":6076740.0,"shares_owned_after_display":"6,076,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-05","scope":"insider"},{"id":6878266,"accession":"0000899243-22-032974","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-032974","line_url":"/filing/0000899243-22-032974#line-1","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28700.0,"shares_display":"28,700","price_per_share":8.779,"price_display":"8.78","price_state":"stated","total_value":251957.3,"total_display":"251,957.30","total_whole":"251,957","shares_owned_after":6080352.0,"shares_owned_after_display":"6,080,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-05","scope":"insider"},{"id":6878017,"accession":"0000899243-22-028680","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-028680","line_url":"/filing/0000899243-22-028680#line-1","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"GreenLight Biosciences Holdings, PBC","issuer_ticker":"GRNA","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3061224.0,"shares_display":"3,061,224","price_per_share":3.92,"price_display":"3.92","price_state":"stated","total_value":11999998.08,"total_display":"11,999,998.08","total_whole":"11,999,998","shares_owned_after":15919155.0,"shares_owned_after_display":"15,919,155","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-11","filed_date":"2022-08-15","scope":"insider"},{"id":9205234,"accession":"0000899243-22-011429","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-011429","line_url":"/filing/0000899243-22-011429#line-1","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"GreenLight Biosciences Holdings, PBC","issuer_ticker":"GRNA","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":null,"owner_name":"MVIL, LLC; Morningside Venture Investments Ltd","owner_display_name":"MVIL, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":13857931.0,"shares_owned_after_display":"13,857,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-03-17","scope":"insider"},{"id":6413223,"accession":"0000899243-22-004855","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-004855","line_url":"/filing/0000899243-22-004855#line-2","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"GreenLight Biosciences Holdings, PBC","issuer_ticker":"ENVI","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":13858188.0,"shares_owned_after_display":"13,858,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-02-04","scope":"insider"},{"id":9205235,"accession":"0000899243-22-011432","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-011432","line_url":"/filing/0000899243-22-011432#line-1","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":null,"owner_name":"MVIL, LLC; Morningside Venture Investments Ltd","owner_display_name":"MVIL, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":263158.0,"shares_display":"263,158","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":5000002.0,"total_display":"5,000,002.00","total_whole":"5,000,002","shares_owned_after":10678808.0,"shares_owned_after_display":"10,678,808","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-11","filed_date":"2022-03-17","scope":"insider"},{"id":6234902,"accession":"0000899243-22-003157","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-003157","line_url":"/filing/0000899243-22-003157#line-2","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Amylyx Pharmaceuticals, Inc.","issuer_ticker":"AMLX","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":263158.0,"shares_display":"263,158","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":5000002.0,"total_display":"5,000,002.00","total_whole":"5,000,002","shares_owned_after":10678808.0,"shares_owned_after_display":"10,678,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-11","filed_date":"2022-01-25","scope":"insider"},{"id":5395852,"accession":"0000899243-21-045265","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-045265","line_url":"/filing/0000899243-21-045265#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":12806342.0,"shares_owned_after_display":"12,806,342","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-18","scope":"insider"},{"id":2077409,"accession":"0001104659-20-011907","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-011907","line_url":"/filing/0001104659-20-011907#line-1","is_derivative":false,"issuer_cik":"0001543112","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001543112","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3800000.0,"shares_display":"3,800,000","price_per_share":2.6,"price_display":"2.60","price_state":"stated","total_value":9880000.0,"total_display":"9,880,000.00","total_whole":"9,880,000","shares_owned_after":6109052.0,"shares_owned_after_display":"6,109,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-04","filed_date":"2020-02-06","scope":"insider"},{"id":3194508,"accession":"0000899243-20-001530","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-001530","line_url":"/filing/0000899243-20-001530#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":540540.0,"shares_display":"540,540","price_per_share":37.0,"price_display":"37.00","price_state":"stated","total_value":19999980.0,"total_display":"19,999,980.00","total_whole":"19,999,980","shares_owned_after":12556342.0,"shares_owned_after_display":"12,556,342","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-13","filed_date":"2020-01-21","scope":"insider"},{"id":8026453,"accession":"0001104659-19-014545","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-014545","line_url":"/filing/0001104659-19-014545#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":441176.0,"shares_display":"441,176","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":7499992.0,"total_display":"7,499,992.00","total_whole":"7,499,992","shares_owned_after":12015802.0,"shares_owned_after_display":"12,015,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-11","filed_date":"2019-03-13","scope":"insider"},{"id":6678643,"accession":"0000899243-18-025079","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-18-025079","line_url":"/filing/0000899243-18-025079#line-3","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":19.84,"price_display":"19.84","price_state":"stated","total_value":793600.0,"total_display":"793,600.00","total_whole":"793,600","shares_owned_after":11574626.0,"shares_owned_after_display":"11,574,626","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-21","filed_date":"2018-09-24","scope":"insider"},{"id":6678640,"accession":"0000899243-18-025079","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-025079","line_url":"/filing/0000899243-18-025079","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":41323.0,"shares_display":"41,323","price_per_share":19.126455726834934,"price_display":"19.13","price_state":"stated","total_value":790362.53,"total_display":"790,362.53","total_whole":"790,363","shares_owned_after":11534626.0,"shares_owned_after_display":"11,534,626","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-20","filed_date":"2018-09-24","scope":"insider","n_lines":2},{"id":6178539,"accession":"0000899243-18-024796","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-18-024796","line_url":"/filing/0000899243-18-024796#line-4","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001543112","owner_name":"Morningside Venture Investments Ltd","owner_display_name":"Morningside Venture Investments Ltd","owner_url":"/insider/0001543112","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":18.09,"price_display":"18.09","price_state":"stated","total_value":1085400.0,"total_display":"1,085,400.00","total_whole":"1,085,400","shares_owned_after":11493303.0,"shares_owned_after_display":"11,493,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-19","filed_date":"2018-09-19","scope":"insider"}],"collapsed":true,"next_cursor":"2018-09-19|6178539","ledger_fault":false,"count":{"value":53,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":17,"open_market":true},{"code":"S","label":"Open-market sale","n":36,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":53},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001745648","name":"Apnimed, Inc.","url":"/issuer/0001745648","role":"Ten percent owner","n_filings":1,"first_seen":"2026-08-05","last_seen":"2026-08-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001658551","name":"Amylyx Pharmaceuticals, Inc.","url":"/issuer/0001658551","role":"Ten percent owner","n_filings":10,"first_seen":"2022-01-25","last_seen":"2023-03-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001645666","name":"Kezar Life Sciences, Inc.","url":"/issuer/0001645666","role":"Ten percent owner","n_filings":12,"first_seen":"2018-06-27","last_seen":"2023-02-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001822691","name":"GreenLight Biosciences Holdings, PBC","url":"/issuer/0001822691","role":"Ten percent owner","n_filings":3,"first_seen":"2022-02-04","last_seen":"2022-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001492422","name":"Apellis Pharmaceuticals, Inc.","url":"/issuer/0001492422","role":"Ten percent owner","n_filings":6,"first_seen":"2017-11-13","last_seen":"2021-11-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001543112","retrieved_at":"2026-08-26T06:22:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}